Nuwellis, Inc. NUWE · Stock Open Nuwellis, Inc. in new tab
Nuwellis, Inc. Analysis (NUWE)
Is Nuwellis, Inc. a good investment? Nuwellis, Inc. (NUWE) is currently trading at 5.33 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.00. This relatively low multiple may signal that Nuwellis, Inc. is undervalued compared to historical market norms.
Earnings Schedule: Nuwellis, Inc. is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is -2.59.
Investor FAQ
Does Nuwellis, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Nuwellis, Inc.?
Nuwellis, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of 3923.28.
Company Profile
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
| Split Date | Split Ratio to 1 |
|---|---|
| Jan. 13, 2017 | 1:30 |
| Oct. 13, 2017 | 1:20 |
| Jan. 3, 2019 | 1:14 |
| Oct. 19, 2020 | 1:30 |
| Dec. 12, 2022 | 1:100 |
| June 28, 2024 | 1:35 |
| July 7, 2025 | 1:42 |
| June 26, 2026 | 1:35 |
| Oct. 27, 2026 | 1:9 |
Community Discussion